AITC treatment using in vivo and in vitro models of COPD was shown to reduce oxidative stress through MRP1, mediated by a reduction in AGE-RAGE-regulated IL-1β and TNFα [52,111,112,113,114,115,116,117]. This evidence concerns the gene AGER and chronic obstructive pulmonary disease.